tirzepatide cardiovascular outcome UC Irvine researchers project cardiac benefits from weight-loss medication Tirzepatide and Cardiovascular Outcomes in

If your B12 levels are already healthy, taking more will not give you extra energy

Front Endocrinol 10:621 McNeill BT, Suchacki KJ, Stimson RH (2021) Mechanisms in endocrinology: human brown adipose tissue as a therapeutic target: warming up or cooling down

Preclinical evidence has suggested that GLP-1R agonists can suppress hepatocellular inflammation and increased oxidative stress indirectly through several cellular pathways that are, in part, independent of weight reduction, since hepatocytes, Kupffer cells, and stellate cells do not express GLP-1Rs [7985]

The complete Thyroid Journal Program includes the highly valued abstract and commentary publication Clinical Thyroidology , led by Editor-in-Chief Trevor E